Search
Search Funnelback University
- Refined by:
- Date: 2020
Your query has been expanded to `News and Events` |u:www.enterprize.cam.ac.uk. Search for `News and Events` |u:www.enterprise.cam.ac.uk instead.
11 -
20 of
25
search results for `News and Events` |u:www.enterprise.cam.ac.uk or `News and Events` |u:www.enterprize.cam.ac.uk
Fully-matching results
-
Horizon Discovery and Eight19 winners at Business Weekly awards –…
https://www.enterprise.cam.ac.uk/news/horizon-discovery-and-eight19-among-winners-at-business-weekly-awards/23 Oct 2020: The Business of the Year was chosen from all the final shortlisted companies and recognised a company which made the largest strides in 2011. ... lighting. By combining solar and mobile phone technology, Eight19 is bringing electricity directly to -
GeoSpock captures space and time to deliver database for IoT –…
https://www.enterprise.cam.ac.uk/news/geospock-captures-space-and-time-to-deliver-database-for-iot/23 Oct 2020: 16 November 2015. GeoSpock captures space and time to deliver database for IoT. ... A new generation of applications use time and place to deliver a customer service. -
Overnight home use of artificial pancreas ‘feasible and beneficial’ – …
https://www.enterprise.cam.ac.uk/news/overnight-home-use-of-artificial-pancreas-feasible-and-beneficial/23 Oct 2020: The success of this trial means that larger and longer studies are already in the pipeline. ... The findings from this study are positive and are certainly worth investigating further. -
PhoreMost and The Wistar Institute collaborate to identify new…
https://www.enterprise.cam.ac.uk/news/phoremost-and-the-wistar-institute-collaborate-to-identify-new-druggable-targets/23 Oct 2020: 10 March 2016. PhoreMost and The Wistar Institute collaborate to identify new druggable targets. ... identify and de-orphan novel targets in cancer, ageing and the immune system. -
Business Weekly and CfEL launch Cambridge Graduate Entrepreneur of…
https://www.enterprise.cam.ac.uk/news/business-weekly-and-cfel-launch-cambridge-graduate-entrepreneur-of-the-year-award/23 Oct 2020: on March 24 at Queens’ College, Cambridge and will then be awarded in perpetuity. ... The organisers will also be contacting relevant organisations and companies already on the radar. -
New treatments for pain and MS being developed in open innovation…
https://www.enterprise.cam.ac.uk/news/new-treatments-for-pain-and-ms-being-developed-in-open-innovation-programme/23 Oct 2020: 25 June 2013. New treatments for pain and MS being developed in open innovation programme. ... Stevenage Bioscience Catalyst is a strong model for the future of university and industry collaboration.”. -
UCL and Cambridge share in £50m of new funding to help UK economy –…
https://www.enterprise.cam.ac.uk/news/ucl-and-cambridge-share-in-50m-of-new-funding-to-help-stimulate-uk-economy/23 Oct 2020: 16 May 2013. UCL and Cambridge share in £50m of new funding to help UK economy. ... create a skilled workforce for the future,” said Minister for Universities and Science David Willetts. -
FlexEnable and ISORG reveal first large area fingerprint and vein…
https://www.enterprise.cam.ac.uk/news/flexenable-and-isorg-reveal-first-large-area-fingerprint-and-vein-sensor-on-plastic/23 Oct 2020: 19 January 2016. FlexEnable and ISORG reveal first large area fingerprint and vein sensor on plastic. ... FlexEnable, to create a flexible fingerprint sensor that is ultra-thin, light, robust and lensless. -
Aurelius and University of Cambridge win Horizon 2020 grant to…
https://www.enterprise.cam.ac.uk/news/aurelius-environmental-university-cambridge-win-horizon-2020-grant-revolutionise-lead-acid-battery-recycling/23 Oct 2020: 24 August 2017. Aurelius and University of Cambridge win Horizon 2020 grant to revolutionise lead-acid battery recycling. ... 2. and NO. 2. ; and lead oxide produced directly from waste batteries” said Dr Fox. -
Boehringer Ingelheim and Funxional Therapeutics announce acquisition…
https://www.enterprise.cam.ac.uk/news/boehringer-ingelheim-and-funxional-therapeutics-announce-acquisition-of-funxionals-fx125l-and-the-somatotaxin-portfolio-to-treat-inflammation/23 Oct 2020: 22 August 2012. Boehringer Ingelheim and Funxional Therapeutics announce acquisition of Funxional’s FX125L. ... team who have delivered first class science and developed a very exciting molecule.
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.